Why is $FATE moving today? · SEC 8-K archive
T0 SEO archive for $FATE: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).
$FATE triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: +0.5/10). Headline: Fate Therapeutics Reports Q3 Net Loss of $30.7M and Updates FT819 Phase 1 Data. Key points: - Q3 net loss narrowed to $30.7M or $(0.25) per share versus $(0.27) per share in Q3 2025. - Total operating expenses down $18.5M YTD, reflecting ongoing cost controls in R&D and G&A. - Reported preliminary Phase 1 clinical data for FT819 showing 100% renal response in selected conditioning regimen.
After the SEC 8-K for $FATE, observed market reaction: T0 price $2.09. Past moves do not guarantee future results.
Stock Catalyst AI pushes real-time SEC 8-K alerts for $FATE via Telegram and the VIP Web Terminal from €10/month.